BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16276527)

  • 1. Bundles of Auer rods in maturing myeloid cells in a case of acute myeloid leukaemia with CBFB::MYH11 rearrangement and concomitant KIT mutation.
    Li THS; Lau WP; Ng KY; Wong WS
    Pathology; 2024 Apr; 56(3):455-457. PubMed ID: 37923609
    [No Abstract]   [Full Text] [Related]  

  • 2. A familial deletion of 10p12.1 associated with thrombocytopenia.
    Manohar S; Gofin Y; Streff H; Vossaert L; Camacho P; Murali CN
    Am J Med Genet A; 2024 Jan; 194(1):77-81. PubMed ID: 37746810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.
    Tsang HC; Bussel JB; Mathew S; Liu YC; Imahiyerobo AA; Orazi A; Geyer JT
    Mod Pathol; 2017 Apr; 30(4):486-498. PubMed ID: 28059092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
    Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
    Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
    Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
    Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
    [No Abstract]   [Full Text] [Related]  

  • 7. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
    Huang L; Abruzzo LV; Valbuena JR; Medeiros LJ; Lin P
    Am J Clin Pathol; 2006 Feb; 125(2):267-72. PubMed ID: 16393685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia in a child with hereditary thrombocytopenia.
    Rheingold SR
    Pediatr Blood Cancer; 2007 Jan; 48(1):105-7. PubMed ID: 16276527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 8;21 translocation in leukemogenesis.
    Peterson LF; Zhang DE
    Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.